Rhythm Pharmaceuticals Stock
Price
Target price
€90.50
€90.50
-1.630%
-1.5
-1.630%
€117.03
05.08.26 / Stuttgart Stock Exchange
WKN: A2H5A0 / Symbol: RYTM / Name: Rhythm Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Rhythm Pharmaceuticals Stock
We can see a decrease in the price for Rhythm Pharmaceuticals. Compared to yesterday it has lost -€1.500 (-1.630%).
With 38 Buy predictions and 1 Sell predictions Rhythm Pharmaceuticals is one of the favorites of our community.
As a result the target price of 117 € shows a positive potential of 29.28% compared to the current price of 90.5 € for Rhythm Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Rhythm Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | -1.630% | -2.162% | -8.122% | 20.667% | -3.209% | 315.138% | 666.949% |
| Evolus Inc | -0.650% | -0.077% | -12.697% | -31.421% | -4.367% | -41.438% | -40.434% |
| Heron Therapeutics Inc. | -1.120% | 1.641% | 16.685% | -72.205% | -61.077% | -71.285% | -95.688% |
| Champions Oncology Inc | 7.420% | -6.286% | 0.408% | -5.385% | -15.172% | -14.435% | -44.091% |
Comments
Rhythm Pharmaceuticals (RYTM) had its price target raised by Citigroup Inc. from $142.00 to $143.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) had its price target raised by Royal Bank Of Canada from $141.00 to $155.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals (RYTM) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $145.00 price target on the stock.
Show more
Ratings data for RYTM provided by MarketBeat